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Abstract
Striking individual differences in severity of group A streptococcal (GAS) sepsis have been noted, even among patients
infected with the same bacterial strain. We had provided evidence that HLA class II allelic variation contributes significantly
to differences in systemic disease severity by modulating host responses to streptococcal superantigens. Inasmuch as the
bacteria produce additional virulence factors that participate in the pathogenesis of this complex disease, we sought to
identify additional gene networks modulating GAS sepsis. Accordingly, we applied a systems genetics approach using a
panel of advanced recombinant inbred mice. By analyzing disease phenotypes in the context of mice genotypes we
identified a highly significant quantitative trait locus (QTL) on Chromosome 2 between 22 and 34 Mb that strongly predicts
disease severity, accounting for 25%–30% of variance. This QTL harbors several polymorphic genes known to regulate
immune responses to bacterial infections. We evaluated candidate genes within this QTL using multiple parameters that
included linkage, gene ontology, variation in gene expression, cocitation networks, and biological relevance, and identified
interleukin1 alpha and prostaglandin E synthases pathways as key networks involved in modulating GAS sepsis severity. The
association of GAS sepsis with multiple pathways underscores the complexity of traits modulating GAS sepsis and provides
a powerful approach for analyzing interactive traits affecting outcomes of other infectious diseases.
Citation: Abdeltawab NF, Aziz RK, Kansal R, Rowe SL, Su Y, et al. (2008) An Unbiased Systems Genetics Approach to Mapping Genetic Loci Modulating
Susceptibility to Severe Streptococcal Sepsis. PLoS Pathog 4(4): e1000042. doi:10.1371/journal.ppat.1000042
Editor: Frederick M. Ausubel, Massachusetts General Hospital, United States of America
Received December 21, 2007; Accepted March 10, 2008; Published April 18, 2008
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: This work was supported by grant AI4 0198-06 from NIH National Institute of Allergy and Infectious Diseases NIAID to M.K., the Research and
Development Office, Medical Research Service, Department of Veterans Affairs (Merit Award to M.K.), and the U.S. Army Medical Research Acquisition Activity
Grant W81XWH-05-1-0227 (to M.K.). Development and maintenance of Gene Network and the BXD Colony is partly supported by INIA and Human Brain Project
funded jointly by the NIMH, NIDA, and NIAAA (P20-DA 21131, U01AA13499 to R.W.W.), NCI MMHCC (U01CA105417 to R.W.W.), and the Biomedical Informatics
Research Network (BIRN), NCRR (U24 RR021760 to R.W.W.).
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mkotb@utmem.edu
Introduction
Infectious diseases, like most human diseases, are modulated by
complex traits. Susceptibility and clinical outcomes of infections
are often a manifestation of interactions between the host’s
complex traits and the pathogen’s virulence components. Identi-
fication of genes and molecular networks that influence host
responses to infectious agents can provide a disease road map that
would focus the discovery of effective diagnostics and therapeutics.
Group A streptococci (GAS) are classified on the basis of surface
M protein antigens into more than 100 serotypes, but recent
studies showed a high degree of diversification within a serotype
that is driven primarily by horizontal gene transfer [1–3]. It is
widely believed that such events are responsible for the emergence
of highly virulent strains in the 1980’s, including a hypervirulent
M1T1 clonal strain, coinciding with the resurgence of severe
invasive GAS infections associated with streptococcal toxic shock
syndrome (STSS) and necrotizing fasciitis (NF), also known as the
‘‘flesh eating’’ disease [4]. We showed that this hypervirulent
M1T1 clinical strain can cause sore throat or mild bacteremia and
erysipelas in some patients, while in others it can cause STSS and
NF [5]. These findings suggested a strong role for host factors in
modulating the outcome of infection by this highly virulent strain.
Indeed, we found that allelic variations in host HLA class II
haplotypes are associated with markedly different outcomes of
GAS sepsis in humans [6,7]. We confirmed these associations
using HLA transgenic mice that were expressing different HLA
class II alleles [8]. Inasmuch as STSS pathogenesis is largely
mediated by streptococcal superantigens (Strep SAgs), and because
HLA class II molecules serve as SAg receptors, such an association
was expected. However, GAS is rich in many other virulence
factors, and we believe that some of those virulence factors, beside
SAgs, may also interact with additional host factors to modulate
host responses to GAS infections.
PLoS Pathogens | www.plospathogens.org 1 April 2008 | Volume 4 | Issue 4 | e1000042To identify additional host factors involved in GAS severity we
needed an approach that allowed us to uncover the effect of
interactions between complex, polymorphic genetic traits that may
modulate sepsis outcomes. Previous animal models for GAS sepsis
included various regular conventional inbred mouse strains [9,10],
congenic strains [11], and HLA transgenic mice [8,12]. These
models confirmed that host genetic variability can have a strong
effect on infection outcome. Despite their significant utility, these
mouse models do not offer the genetic diversity that is
characteristic of the human population.
In this study, we used a panel of advanced recombinant inbred
(ARI) mice as a genetically diverse, segregating reference
population that affords a powerful tool for systems genetics
approaches. Recombinant inbred (RI) strains have been success-
fully used to map quantitative trait loci (QTLs) associated with
various phenotypes and diseases [13–20]. We used the BXD panel
of ARI mice derived from C57BL/6J (B6) and DBA/2J (D2)
strains and consisting of homozygous, inbred BXD lines, each of
which is genetically distinct. Using this genetically diverse BXD
panel, we mapped QTLs modulating GAS sepsis severity, and
identified candidate genes within these QTLs that were parsed
into pathways likely to modulate the severity of this complex
infectious disease.
Results
Variable susceptibility to severe GAS sepsis in genetically
distinct mice
Our initial studies [20] demonstrated that there is considerable
variability among BXD strains with respect to susceptibility to
severe GAS sepsis. To quantify differences among strains in this
study, we used three main quantitative traits, namely animal
survival, bacteremia, and bacterial dissemination to spleen.
We infected mice (n=5–26 mice per strain), belonging to 32
strains (30 different BXD strains and their parental strains, B6 and
D2), intravenously (i.v.) with the same bacterial dose (261.5610
7
CFU/mouse). Survival was expressed as normalized corrected
relative survival indices (cRSI) calculated for each of the 32 strains
as detailed in materials and methods. We observed significant
difference in relative susceptibility to GAS sepsis across the BXD
panel (P#0.0001), Figure 1A. This wide range of susceptibility
across the various strains, together with the finding that some of
the strains showed phenotypes considerably more exaggerated
than the parental strains (B6 and D2), is an illustration of how
different combination of polymorphic genes can manifest quite
differently according to the overall genetic context.
Similarly, we determined bacterial load in blood (log CFU/ml
blood), 24 h post-infection and found considerable variation across
the strains. In general there was an inverse correlation between
mice survival and extent of bacteremia (r=20.471, P#0.0001,
R
2=22.2%), Figure 1B. Bacterial dissemination to spleen also
varied across the strains, showing a stronger inverse correlation
with mice survival (r=20.717, P#0.0001, R
2=51.4%),
Figure 1C.
Although these inverse correlations between mice survival and
bacterial load in blood and spleen made biological sense because it
is anticipated that susceptible strains would have higher bacterial
load than in resistant strains, there were several exceptions. For
example, although strains BXD44, and BXD45 are ranked
susceptible based on their survival, they showed low bacterial
load in blood and spleen. Similarly, BXD43 and BXD85 strains,
which are ranked resistant, had a high bacterial load in their
spleen. Another interesting observation was that, in general,
susceptible strains survival was better correlated with bacterial load
in blood and spleen than resistant strains. Together, these findings
confirm that there is more than one mechanism modulating
differential susceptibility or resistance to severe GAS sepsis [20].
Genome-Wide Scans for Mapping GAS Susceptibility
QTLs
We used bioinformatics tools available through Gene Network
(GN) to link measured phenotypes to strains genotypes. Each of
the quantified phenotypes was analyzed in the context of the
studied mice genotypes and single nucleotide polymorphism
(SNPs) using 3795 SNPs and microsatellite markers for BXD
strains. Significant QTLs modulating survival, bacteremia 24 h
post-infection, and bacterial dissemination to spleen mapped to
mouse Chromosome (Chr) 2.
The strongest QTL modulating mouse survival (cRSI) mapped
to mouse Chr 2 between 22–34 Mb, with an likelihood ratio
statistic (LRS) of 34.2 (P#0.0000001), Figure 2A. A second less
significant QTL was also mapped on the same chromosome
between 125–150 Mb with an LRS of 12 (P#0.001), and a third
QTL on Chr X, Figure 2A. The QTLs for bacteremia and
bacterial dissemination to spleen overlapped with those for
survival, with slight difference in significance. The first QTL
modulating bacteremia mapped to Chr 2 between 22–34 Mb with
an LRS of 24.5 (P#0.00001), Figure 2B. The second QTL
mapped to the same chromosome between 125–150 Mb with an
LRS of 17 (P#0.0001), Figure 2B. A QTL modulating bacterial
dissemination to spleen also mapped to Chr 2 between 125–150
Mb with LRS of 15 (P#0.001), Figure 2C.
To further investigate and narrow down the mapped region on
Chr 2, we resorted to haplotype maps of BXD strains to select
additional strains that may be informative in validating, and
further confirming mapped QTLs.
In silico prediction of BXD susceptibility to severe GAS
sepsis
Our mapped QTLs directed us to select more strains for
survival experiments based on differences in their haplotypes
Author Summary
Group A streptococci (GAS) cause a wide variety of human
diseases ranging from mild pharyngitis to streptococcal
toxic shock syndrome and necrotizing faciitis. Our previous
studies have shown that host immunogenetic variation
can dictate the clinical outcome of GAS sepsis. As in most
human disease, GAS sepsis is likely to be affected by
complex interactions between more than one polymor-
phic gene. We addressed this issue in our study where we
present an approach that allowed us to identify multi
genetic factors that likely contribute to sepsis severity. We
mapped susceptibility to severe GAS sepsis to quantitative
trait loci on Chromosome 2 using a panel of genetically
diverse inbred mice. The mapped regions have high single
nucleotide polymorphism (SNP) density that harbor genes
known to play an important role in innate immune
response to bacteria. Several of those genes are differen-
tially expressed between susceptible and resistant strains
of mice. Our overall approach of systematic dissection of
genetic and molecular basis of host susceptibility is not
unique to GAS infections, but can be applied to other
infectious diseases to develop better diagnostics, design
effective therapeutics and predict disease severity based
on a set of genetic and soluble biomarkers.
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haplotype at Chr 2 between 22–34 Mb region, Figure 3A, and
found it to be susceptible. Similarly, we tested BXD87 with a B
haplotype in the same region and this strain as predicted, exhibited
a resistant phenotype. To further narrow down the mapped
QTLs, we chose strains with breakage in the mapped interval, i.e.
with recombination at Chr 2 region 22–34 Mb for further survival
testing (Figure 3A). BXD34 with a B haplotype at Chr 2 between
24–33.15 Mb region, was resistant, while BXD60 with a B
haplotype at Chr 2 between 20–23.27 Mb region, was susceptible,
Figure 1A and 3A. This narrowed down the relevant susceptibility
region to Chr 2 between 23.27–33.15 Mb. Using more strains with
recombination at this narrowed region, we found BXD51, 64, and
79 to be quite interesting as they showed intermediate resistance
suggesting that genes at this region are candidate modulators of
the mapped QTL, Figure 3B. Another interesting strain was
BXD94 that we found susceptible to infection, yet has a
heterozygous genotyping, suggesting that D allele exhibited
dominance, Figure 3B.
Similarly, we inspected haplotypes of studied BXD strains at the
second QTL between 125–150Mb (Figure 3C), the majority of
susceptible strains had D alleles, while resistant strains had B alleles
with some exceptions, for example BXD77 is a susceptible strain,
yet had B alleles. It was interesting to find that the susceptible
strain BXD44 had B alleles at this QTL (Figure 3C), suggesting
that observed lower bacterial load in blood compared to other
susceptible strains (Figure 1B) might be modulated by B allele in
the second QTL. Meanwhile, BXD48, a resistant strain, has a
breakage at 135.9 Mb (Figure 3C) with D alleles suggesting that its
relatively higher bacterial load in blood (Figure 1B) might be
modulated by the second QTL. Collectively, these findings suggest
that both loci modulate different observed phenotypes of GAS
sepsis severity.
Mining for candidate genes and pathways in mapped
loci
Based on our in silico strain selection and QTL validation by
experimental assessment, we evaluated candidate genes within the
mapped QTLs, taking into account linkage, gene ontology
analyses, cocitation networks, and biological relevance. To
categorize genes and transcripts in the mapped QTLs into
functional pathways, we performed functional analyses using
Ingenuity Pathways Analysis (IPA) (www.ingenuity.com). We
parsed our genes into 50 functional networks; the most relevant
networks involved those associated with immune response, cell
signaling, cellular assembly and organization, and lipid metabo-
lism. From these interrelated pathways, we selected 37 represen-
tative genes to study their role in GAS susceptibility QTL by
quantitative analysis of their expression levels in selected resistant
and susceptible strains (groups) pre- and post-infection (Table S1).
Figure 1. Differential susceptibility to GAS sepsis among
different BXD strains and their parental strains. (A) Rank-ordered
bar chart of survival expressed as mean values of coefficient of mean
corrected relative survival indices (cRSI) across 30 different BXD strains
and their parental strains (DBA/2J and C57Bl/6J) at the two extremes of
the X-axis. Error bars represent the standard errors of the means.
Statistical test is two-way ANOVA (with correction to covariates)
P#0.0001. Total number of mice is 489 belonging to 32 strains;
number of mice used per strain is indicated. (B) Bar chart of GAS
bacteremia expressed as coefficient of mean values of corrected log
blood CFUs 24 h post injection (corrected log CFU/ml blood). Strains
are ordered by their corrected relative survival indices with the parental
strains at the two extremes of the X-axis. Error bars represent the
standard errors of the means. Statistical test is two-way ANOVA (with
correction to covariates) P#0.0001. (C) Bar chart of GAS dissemination
to spleen expressed as coefficient of corrected bacterial load in spleen
(log CFU/spleen). Strains are ordered by their corrected relative survival
indices with the parental strains at the two extremes of the X-axis. Error
bars represent the standard errors of the means. Statistical test is two-
way ANOVA (with correction to covariates) P#0.0001.
doi:10.1371/journal.ppat.1000042.g001
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PLoS Pathogens | www.plospathogens.org 3 April 2008 | Volume 4 | Issue 4 | e1000042Figure 2. Genome-wide scan for mice susceptibility to GAS sepsis showing mapped QTL on Chr 2. (A) Interval mapping of survival
(expressed as corrected relative survival index, cRSI), showing a significant QTL (based on 1000 permutation tests) on Chr 2 between 22–34 Mb with
LRS of 34.2 (P#0.0000001), and a suggestive QTL between 125–150 Mb with LRS of 12 (P#0.001). (B) Whole genome interval mapping of GAS
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differentially expressed post-infection (Table S2), of those 14 genes
were down regulated in resistant group while up regulated in
susceptible group post-infection. Nine genes were down regulated
in both groups post-infection, and five were up regulated in both
groups post-infection (Table S2). Fourteen of the 28 differentially
expressed genes showed significant change post-infection in both
resistant and susceptible strains (Table 1 and Figure 4). In general,
susceptible strains showed increase in the relative expression levels
post-infection (19 genes) of both pro and anti-inflammatory genes,
e.g. interleukin1 alpha (Il1 a), and Il1 receptor antagonist (Il1rn)
respectively. By contrast, in the resistant BXD strains, most of the
tested genes showed a decrease (23 genes) in expression levels post-
infection with few exceptions (five genes) e.g. TNF receptor
associated factor 1 (Traf1) (Figure 4 and Table S2). Differentially
expressed genes were associated with both innate and early
adaptive immune response. Among those associated with early
immune response, Il1a, Il1rn, prostaglandin E synthase (Ptges), and
Ptges2 were up regulated in susceptible strains, whereas their levels
decreased in resistant strains. Several of the differentially expressed
genes show polymorphisms as SNPs between the parental strains
B6 and D2, suggesting that these polymorphic genes modulate
differential response to infection (Table S3). The differential
expression of IL-1a was confirmed at the protein level (data not
shown).
We parsed the differentially expressed genes into pathways,
using IPA, IL-1 and prostaglandins were key early response
molecules modulating susceptibility to severe GAS sepsis in two
the mapped networks, which are shown merged in Figure 5. The
first network (P,10
227) comprised of genes related to lipid
metabolism and innate immunity, e.g. Il1a, Il1rn, Ptges, while
second network (P,0.01) contained genes modulating nucleic acid
metabolism, energy production and host responses to injury e.g.
Ectonucleoside triphosphate diphosphohydrolase 2 (Entpd2)
(Figure 5).
Discussion
It has been established that networks of multiple pathways,
rather than a single gene, modulate traits and affect susceptibility
and outcomes of virtually all diseases. The ARI strains used in this
study afford one of the best unbiased forward genetics approaches
to determine how different combinations of polymorphic genes
interact to shape disease phenotypes. Using this panel of
genetically diverse reference population, we were able to map
QTLs modulating specific phenotypes associated with severe GAS
sepsis.
GAS causes a wide range of diseases depending on multiple
factors including site and route of infection, interplay of the
pathogen virulence factors with host immune defenses that are
affected by the host immune status and difference in the genetic
make up of the host [6]. Thus, these bacteria represent a good
model to explore the impact of host complex traits on susceptibility
to infections. Previous studies have shown that host-pathogen
interactions modulate the severity of GAS sepsis [5,6,9,10], and we
found that patients with GAS sepsis expressing HLA class II
DRB1*15/DQB1*06 (DR15/DQ6) haplotype are protected from
severe GAS sepsis, whereas those with HLA class II DRB1*14/
DQB1*05 (DR14/DQ5) haplotype are at high risk for developing
severe and often fatal forms of the disease [6]. The strong
association between disease severity and HLA class II allelic
polymorphism is primarily related to the differential ability of
HLA class II alleles to present SAgs to T cells, where presentation
of Strep SAgs by the protective HLA class II alleles results in a
significantly attenuated response as compared to their presentation
by the neutral or high-risk alleles [6,8,21]. While this association
made perfect biological sense based on the known central role of
SAgs in the human disease, mice are not susceptible to SAgs due to
an inherent lower affinity of mouse MHC class II molecules to
GAS SAgs. The role of GAS SAgs can be well investigated in HLA
class II transgenic mice as others and we have reported
[8,12,22,23]. However, due to the overwhelming response to
SAgs in these mice, it is difficult to use them to dissect host
response to other GAS virulence factors in the disease process. For
this reason, our present ARI mouse model of sepsis is ideal for
identifying host genetic variations, besides the MHC class II
antigens, that may also contribute to differences in GAS sepsis
severity.
We invested time and effort to standardize the GAS infection
model using a large number of BXD mice (n=717) and this
allowed us to optimize infection dose and identify significant
covariates (e.g. age and sex) needed to be accounted for in our final
analysis [20]. Although GAS strains can vary considerably with
regards to virulence, we showed that the same virulent strain could
cause diseases with starkly different severity in humans [5,6]. The
strain used in this study is a hypervirulent derivative of the M1T1
clonal strain that emerged in the 1980’s at the same time that the
severe forms of the invasive GAS infections resurged [3,24–26].
Initial studies [20] identified an optimal infection dose of
261610
7 CFU/mouse, and indicated the need to use mice with
an age range of 40–120 days for linear correlation with survival. In
addition, these pilot studies determined that sex has insignificant
effect in this GAS sepsis model [20] and revealed a stark variation
among various BXD strains used with respect to their susceptibility
to severe sepsis. However, precise mapping of QTLs required that
we study more BXD strains and include more mice per BXD
strain to obtain statistical power.
With a total of 30 BXD strains and an average of 15 mice per
strain, we mapped QTLs on Chr 2 that modulate severity to GAS
sepsis, measured by comparing mice survival post-infection,
bacterial load in blood, and bacterial dissemination to spleen
across the BXD strains. Inasmuch as the BXD strains are heavily
genotyped with more than 3600 genomic markers, identifying
QTLs is relatively straightforward. The mapped QTLs on Chr 2
harbor a relatively large number of candidate genes associated
with various functional networks and signaling pathways including
nuclear factor-kB (NF-kB) and p38 mitogen activated protein
kinases (MAPK) pathways, proliferation of immune cells, and
eicosanoid signaling. Such output is typical of unbiased genome-
wide analysis studies, and required further analyses to determine
which of these genes are the key modulators of the studied trait.
To narrow down the gene list to a handful of genes that can be
experimentally validated, we used multiple methods including
linkage, gene ontology, and differential gene expression analyses.
Our quantitative PCR analysis of 37 representative candidate
bacteremia using bacterial load 24 h post injection expressed as corrected log CFU/ml blood, showing two QTLs on Chr 2: first QTL between 22–34
Mb with LRS of 24.5 (P#0.00001) and a second with LRS of 17 (P#0.0001) between 125–150 Mb. (C) Whole genome mapping of GAS sepsis using
tissue dissemination of GAS expressed as corrected log CFU/spleen with QTL between 125–150 Mb with LRS of 15 (P#0.0001). Red line indicates
significant LRS, while grey line indicates suggestive LRS. Upper x-axis shows mouse chromosomes, and lower x-axis shows physical map in mega
bases, y-axis represents linkage in LRS score.
doi:10.1371/journal.ppat.1000042.g002
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PLoS Pathogens | www.plospathogens.org 5 April 2008 | Volume 4 | Issue 4 | e1000042Figure 3. Recombinant inbred BXD strain distribution patterns at region of interest on Chr 2. (A) Haplotype maps of the first QTL on Chr
2 between 20–34 Mb showing available BXD strains. Haplotype maps were used for in silico selection of strains for survival studies based on the strain
distribution patterns, where B allele (blue bars) inherited from the resistant parent C57Bl/6J and D alleles form the susceptible parent DBA/2J, beige
bars indicate strains that are heterozygous at this region, resembling an F1. Arrows indicate BXD strains 34, 51, 60, 64, 79, 94, and 100. (B) Haplotype
maps of the first QTL region on Chr 2 between 20—34 Mb across BXD strains used in the population-based survival experiments showing the pattern
of alleles inherited from each parent at region of interest on Chr 2. The different BXD strains are rank-ordered according to their susceptibility to GAS
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PLoS Pathogens | www.plospathogens.org 6 April 2008 | Volume 4 | Issue 4 | e1000042genes showed that 28 genes were differentially expressed in
selected susceptible and resistant strains post-infection. These
differentially expressed genes fell into three main categories, genes
associated with innate and adaptive immune response, and genes
associated with apoptosis. Differentially expressed genes associated
with innate immune response were both pro- and anti-inflamma-
tory as well as adaptive immune response genes associated with T
and B cell proliferation and differentiation, cell signaling and
antigen processing and presentation.
Differentially expressed genes associated with innate immune
response were either related to pro- or anti-inflammatory
responses. Both pro- and anti-inflammatory associated genes were
up-regulated in the selected susceptible strains post-infection, and
this is in agreement with a recent study by Goldmann, et al. [27]
who showed a mixed pro- and anti-inflammatory response
belonging to M1 and M2 macrophage phenotypes in response
to GAS infection. This increase in both pro- and anti-
inflammatory response could be attributed to homeostatic
mechanisms where, for example, the increase in Il1 levels in the
susceptible strains was accompanied by an increase in its
endogenous antagonist Il1rn. This was not the case in the resistant
strains that showed decreased levels of expression of pro- and anti-
inflammatory related genes both pre- and post-infection. These
findings suggest that susceptibly to GAS sepsis is associated with an
overzealous innate immune response as observed in susceptible
BXD strains only. These results mirror previous findings in
humans, where association of exaggerated inflammatory respons-
es, including IL-1, with susceptibility to GAS sepsis was detected
[6,28,29]. However, unlike what we found in this mouse model,
human responses are dominated by high levels of IFN-c and TNF-
ß, presumably because the human disease is driven primarily by
SAgs [29,30].
In general, differentially expressed genes associated with early
adaptive immune responses showed a pattern of decrease in
expression levels in both susceptible and resistant strains with the
exception of anaphase promoting complex subunit 2 (Anapc2) that
was slightly increased in susceptible strains post-infection (Figure 5).
By contrast, several genes associated with pro- and anti-apoptotic
response were differentially expressed in the selected susceptible
and resistant strains post-infection (Figure 5). Apoptosis in
streptococcal pathogenesis is affected by interacting factors
including, context of infection [31], cells undergoing apoptosis
[32–34], for example, apoptosis aids in the clearing of infection if
macrophages are undergoing apoptosis, while it would be harmful
to the host if lymphocytes are undergoing apoptosis. Other factors
include, whether the bacteria is internalized or extracellular [35]
and accordingly the type of apoptosis pathways activated [36]. In
our murine GAS sepsis model, we have measured expression levels
in whole spleens, which involved the response of various cells
including macrophages, T and B lymphocytes, dendritic and
sepsis form susceptible to more resistant. Resistant strains show a pattern of accumulation of alleles inherited from resistant parent (B) C57Bl/6J (blue
bars) while the susceptible strains show a pattern of alleles from susceptible parent (D) DBA/2J (red bars), with the exception of BXD94 strain,
heterozygous (beige bars) at the QTL region. (C) Haplotype maps of the second QTL region on Chr 2 between 125—150 Mb across BXD strains used
in the population-based survival experiments showing the pattern of alleles inherited from each parent at region of interest on Chr 2. The different
BXD strains are rank-ordered according to their susceptibility to GAS sepsis form susceptible to more resistant. BXD genotype data set can be
downloaded from www.genenetwork.org/genotypes/BXD.geno.
doi:10.1371/journal.ppat.1000042.g003
Table 1. The relative expression levels of candidate genes post infection in resistant and susceptible strains expressed as ratio of
post/pre infection in susceptible and resistant strains.
Gene ID Gene Resistant strains P value
a Susceptible strains P value
Genes down regulated in resistant group while up regulated in susceptible group
Anapc2 Anaphase promoting complex subunit 2 0.551 0.022* 1.475 0.509
Il1 a Interleukin 1 a 0.739 0.010* 44.525 0.062 {
Il1rn Interleukin 1receptor antagonist 0.851 0.680 54.687 0.221
Ptges Prostaglandin E synthase 0.417 0.001 * 6.363 0.028 *
Ptges2 Prostaglandin E synthase 2 0.913 0.774 1.456 0.005 *
Sh2d3c SH2 domain containing 3C 0.162 0.055 { 1.009 0.980
Genes down regulated in both resistant group and susceptible groups
Entpd2 Ectonucleoside triphosphate diphosphohydrolase 2 0.359 0.010* 0.654 0.064 {
Edf1 Endothelial differentiation-related factor 1 0.349 0.095 { 0.470 0.014 *
Garnl3 GTPase activating RANGAP domain-like 3 0.601 0.142 0.674 0.070 {
Nfatc2 Nuclear factor of activated t-cells, cytoplasmic, calcineurin-dependent 2 0.178 0.095 { 0.693 0.208
Phpt1 Phosphohistidine phosphatase 1 0.229 0.077 { 0.714 0.233
Psmd5 Proteasome (prosome, macropain) 26S subunit, non-ATPase 5 0.644 0.006 * 0.963 0.652
Ppp2r4 Protein phosphatase 2A regulatory subunit B 0.902 0.256 0.734 0.091 {
Genes up regulated in both resistant group and susceptible group
Traf1 TNF receptor associated factor 1 1.826 0.300 5.995 0.066 {
aSignificance based on t-test,
*P,0.05,
{P=0.06–0.08.
doi:10.1371/journal.ppat.1000042.t001
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mixed response; however, in our ongoing studies, we are
examining possible alterations in splenic population profiles post-
infection in the various BXD strains to determine which cell types
are responsible for the major differences in cytokine levels seen
post-infection and to dissect the role of different cell populations in
this GAS sepsis model.
Another interesting observation was that the relative expression
level of genes measured in the selected resistant strains showed a
pattern of decrease post-infection, with the exception of five genes,
heat shock 70KDa protein 5 (Hspa5), Traf1, Traf2, Notch gene
homolog 1 (Notch1), and signal-regulatory protein alpha (Sirpa). It is
worthy to note the link between these genes is as they are involved
directly and indirectly with activation of early adaptive response.
Hspa5 is an Hsp70, which is associated with cytoprotection, anti-
apoptosis, and anti-inflammation [37–39], and has been associated
with immune response to sepsis [40,41]. Notch1 has been associated
with the signaling involved in regulation of lymphocytes
development and activation to effector cells [42], natural killer
cells development [43–45] and recently Notch1 was associated with
macrophage activation [46].We took into consideration in our
experimental design that stress might alter the expression of stress
related genes especially heat shock proteins and chemokines,
therefore, we subjected control mice to the same stress as infected
mice by injecting control mice with saline, so that any change in
expression levels would be accounted to GAS sepsis.
Among the differentially expressed genes, four genes, Il1, Il1rn,
Ptges, and Ptges2, showed marked up regulation in susceptible
strains, while showed no change or slight decrease in levels in
resistant strains post-infection (Figure 5). Expression of Ptges and
Ptges2 genes increase is induced by the increased levels of Il1 [47],
which is an indirect effect of the activation of IFN-c (Figure 5).
Ptges and Ptges2 are prostaglandins synthases for the lipid
inflammatory mediators PGE2, which along with platelet
activating factor and leukotriens, mediate vasodilatation in the
early response to inflammation [48,49]. Vasodilatation in turn
leads to hypotension, a hallmark of STSS. Although the role of
prostaglandins in inflammation and immune response has long
been studied, their role in the immune response to infectious
diseases has been lately pursued [50–55]. Increased production of
prostaglandins has been associated with various Gram positive
bacterial infections including Streptococcus suis [53], group B
streptococcal [55], and GAS skin infections [54].
In conclusion, our holistic approach of studying the genetic basis
of differential susceptibility to GAS sepsis revealed loci on Chr 2
that harbor major immune modulators. In the present study, we
examined the interactions of pathogen multiple virulence factors
with the host immune system in an in vivo model of sepsis using a
genetically diverse reference population. This shed light on a
network of host genes modulating variation in GAS severity, which
includes cytokines, pro- and anti-inflammatory mediators, and
genes associated with apoptosis and early adaptive immune
response. Our ongoing detailed studies to identify interactive
molecular pathways contributing to the complex trait of GAS
sepsis will undoubtedly help us dissect the various mechanisms by
which the host interacts with the bacteria in vivo, resulting in
resistance or increased susceptibility to severe GAS sepsis.
Materials and Methods
Mice
We generated the BXD advanced recombinant inbred (ARI)
mice at UTHSC by crossing B6 and D2 mice to generate F1
hybrids, which were crossed to generate F2 progeny, each with
Figure 4. Patterns of differential gene expression levels of candidate genes post infection in susceptible and resistant strains.
Quantitative PCR results showing levels of gene expression of 14 genes with significant (P=0.05–0.08) change post-infection in susceptible and
resistant strains, expressed as Log fold differences in gene expression level post-infection. Genes are grouped to three groups, a) genes up regulated
in susceptible strains post-infection and decreased in resistant strains post-infection, b) genes down regulated in both susceptible and resistant
strains post-infection, and c) genes up regulated in both susceptible and resistant strains post-infection. Susceptible strains are represented as solid
black bars, and resistant strains as dashed bars. The bars represent 2–4 biological replicates run in three technical replicates each and significance is
based on t-test. Anapc2, anaphase promoting complex subunit 2; Entpd2, ectonucleoside triphosphate diphosphohydrolase 2; Edf1, endothelial
differentiation-related factor 1; Garnl3, GTPase activating RANGAP domain-like 3; Il1a, interleukin 1 alpha; Il1rn, interleukin 1receptor antagonist;
Nfatc2, nuclear factor of activated t-cells, cytoplasmic, calcineurin-dependent 2; Phpt1, phosphohistidine phosphatase 1; Ptges, prostaglandin E
synthase; Ptges2, prostaglandin E synthase 2; Psmd5, proteasome (prosome, macropain) 26S subunit, non-ATPase 5; Ppp2r4, Protein phosphatase 2A
regulatory subunit B; Sh2d3c, SH2 domain containing 3C; Traf1, TNF a receptor associated factor 1.
doi:10.1371/journal.ppat.1000042.g004
Genetic Susceptibility to S. pyogenes Sepsis
PLoS Pathogens | www.plospathogens.org 8 April 2008 | Volume 4 | Issue 4 | e1000042random patterns of recombination. Random crossing of F2 mice
generated F3 and so on, till F11 generation, after which we
designated pairs of F11 hybrids as parents of each BXD line, and
inbred them by sib mating for .20 generations to achieve
homozygosity for each genetically distinct BXD line. This
breeding scheme was done to increase recombination events
resulting in roughly double the number of recombinations per
strain compared to conventional RI strains [56,57].
The genomes of the B6 and D2 parental strains have been
sequenced and a database of their SNPs is available at the Gene
Network (GN) web site (www.genenetwork.org/webqtl/snpBrowser.
py). Simple sequence length polymorphism (SSLP) markers were
typed for all BXD RI strains as previously described [56]. The BXD
progeny is genotyped at 13377 SNPs and microsatellite markers
[58], a selected subset of 3795 SNPs and microsatellite markers used
by GN BXD genotype dataset for mapping traits, can be
downloaded at www.genenetwork.org/genotypes/BXD.geno.
We recently standardized the model of BXD ARI mice for use
in GAS infection studies [20]. In the current study, a total of 696
mice were used, from which 183 flagged mice were excluded based
on predetermined criteria as previously detailed in [20].
All procedures involving mouse tissues were approved by the
institutional animal care and use committee at the UTHSC.
Experimental design
A) Population-based experiments. Groups of 5–26 mice
from a total of 30 BXD lines and their parental strains (B6 and D2)
were injected via tail vein with 261.5610
7 CFU/mouse of a
hypervirulent form of the clinical isolate GAS 5448 (M1T1)
[5,24,59] as detailed previously [20]. Mortality and weight loss
were recorded every 8 h for the ensuing 6 days. To normalize
across experiments, we inspected survival days distribution clusters
for each experiment and determined multimodal distribution and
boundaries of each cluster for a total of three clusters: susceptible,
intermediate, and resistant. Survival days within each cluster were
then converted into a survival index ranging from 0.25–1, 1.25–2,
and 2.25–3 for susceptible, intermediate, and resistant clusters
respectively. The survival index was assigned to each mouse
irrespective of its strain. Indices for each strain, across experiments
were then corrected for significant covariates (age, sex, body
weight, and inocula) using multiple regression analyses.
B) Phenotype assessment experiments. We designed
experiments for the assessment of survival, bacteremia, and
bacterial dissemination to spleen. We assessed relative mice
survival and bacteremia in the same experiment. We measured
bacteremia as CFU/ml by culturing serial dilutions of blood
drawn from mice tails 24 h post-injection. We determined
Figure 5. Functional network of genes modulating GAS QTL. Graphical representation of the molecular relationships between differentially
expressed genes, showing the central role of IL-1, IL-1rn, PTGES, and PTGES2 in modulating response to GAS sepsis and their indirect interactions with
IFN-c and IL-2 networks in modulating bacterial sepsis. Genes are represented as nodes, and the biological relationship between two nodes is
represented as line, solid lines represent direct interactions, dashed lines represent indirect interactions. Oval shapes represent chemical or drug,
squares represent cytokines, diamond shapes represent enzymes, concentric circles represent group of family, and triangles represent phosphates.
Blue lines and arrows represent expression levels of resistant strains, while red lines and arrows represent susceptible strains expression levels.
Apyrase, ATP diphosphohydorlase; ANAPC2, anaphase promoting complex subunit 2; CDC20 cell division cycle homolog 20; CXCL14, chemokine (c-x-
c motif) ligand 14; ENTPD2, ectonucleoside triphosphate diphosphohydrolase 2; EDF1, endothelial differentiation-related factor 1; JUN jun oncogene;
IL1A, interleukin 1 alpha; IL1RN, interleukin 1receptor antagonist; IFNG interferon gamma; IL2 interleukin2; PDCD1LG2, programmed cell death ligand
2; PTGES, prostaglandin E synthase; PTGES2, prostaglandin E synthase 2; PSMC3 proteasome (prosome, macropain) 26S subunit ATPase 3; PSMD5,
proteasome (prosome, macropain) 26S subunit, non-ATPase 5; PPP2R4, protein phosphatase 2A regulatory subunit B; RBM39, RNA binding protein
39; SH2D3C, SH2 domain containing 3C; SLC6A6, solute carrier family 6; TP53 tumor protein p53; TP53RK, TP53 regulating kinase; VTCN1, V-set
domain containing T cell activation inhibitor 1.
doi:10.1371/journal.ppat.1000042.g005
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using tissue homogenizer, TH (Omni International, Marietta,
GA). Each tissue homogenate was serially diluted 10 folds to 10
26
fold, and each dilution was cultured for determination of bacterial
load in spleens (CFU/ml) that was then normalized to spleen
weight and expressed as CFU/spleen.
QTL Mapping
We performed QTL mapping using web-based complex trait
analysis available on the GN website and the mapping module
which analyzes phenotypes in context of mouse genotypic
differences. Interval mapping evaluates potential QTL at regular
intervals and estimates the significance at each location using 1000
permutation tests [60]. We performed three sets of analyses using
strain means for the following three variables: (1) corrected relative
survival index, described above, (2) log bacterial load in blood 24 h
post injection, and (3) log bacterial load in spleen at expiration.
Quantitative PCR analysis for target genes expression
We investigated the differential expression of target genes in
spleen of infected vs. control PBS-injected mice at selected time
points, we selected strains based on their susceptibility, BXD61
and 90 representing susceptible strains, and BXD73 and 87,
representing resistant strains. We performed 2–3 biological
replicates of each set of paired susceptible and resistant (n=6–8
per strain). Mice were sacrificed 40 h post i.v. injection with
261.5610
7 CFU/mouse of clinical isolate GAS 5448 (M1T1) and
RNA from individual mice was extracted from spleens. Bacteremia
was determined as described above. We isolated RNA using RNA-
STAT 60 method and when necessary, we purified RNA samples
using RNeasy mini kit clean up columns (Qiagen, Valencia, CA).
We pooled RNA samples per strain with A260/280 ratios$1.8 for
cDNA synthesis with SuperScript III reverse transcriptase kit
(Invitrogen, Carlsbad CA) using oligo dT primers. We designed
real time PCR assays, hydrolysis probes, and gene specific primers
that span long introns to distinguish cDNA from genomic DNA
using primer design online software universal probe library (UPL)
at www.roche-applied-science.com/sis/rtpcr/upl/index.jsp. We
performed quantitative TaqMan PCR on light cycler LC480
(Roche Applied Science, Indianapolis, IN). We used the mouse
housekeeping gene, hypoxanthine guanine phosphoribosyl trans-
ferase (Hprt1) as an endogenous control to which we normalized
gene expression data. Primer sequences are listed in Table S1.
Samples were analyzed in triplicates for each of 2–4 biological
replicates. We used delta delta Ct (threshold cycle) method for
calculating relative expression levels expressed as fold differences
between pre- and post-infection values for each gene analyzed.
Student t-test was used to assess statistical significance.
Identification of differentially expressed genes in the
mapped interval and bioinformatics functional pathways
analyses
We generated functional analyses of genes within the QTLs
using Ingenuity pathways analysis (IPA) (www.ingenuity.com).
Each data set containing gene identifiers was uploaded into the
online application, and each gene was overlaid onto a molecular
network developed from information contained in the ingenuity
pathways database. Networks of genes were then generated based
on their connectivity, and we chose the top 50 significant
networks. The significance of the association between the data
set and the pathways was measured in two ways: (1) the ratio of the
number of genes from the data set that map to the pathway
divided by the total number of genes that map to the pathway; and
(2) by Fischer’s exact test with P,0.001.
Statistical analysis. We used the DataDesk 6.2 (www.
datadesk.com) to calculate mean survival indices, corrected
survival indices, and correlation coefficients. Covariates
association was evaluated for significant associations by
Spearman correlation as described previously [20]. Fischer exact
test was used to analyze association of the analyzed differentially
expressed genes with specific pathways.
Web site URL
Our data sets stored in WebQTL can be found at Gene
Network (www.genenetwork.org) under BXD published pheno-
types record ID 10836.
Supporting Information
Table S1 Primer sequences used in quantitative PCR assays for
candidate genes.
Found at: doi:10.1371/journal.ppat.1000042.s001 (0.08 MB DOC)
Table S2 Relative expression levels of candidate gene list
expressed as mean fold difference between pre- and post-
infection6standard deviation (SD) in selected resistant and
susceptible strains.
Found at: doi:10.1371/journal.ppat.1000042.s002 (0.09 MB DOC)
Table S3 SNP analysis between parental strains C57Bl/6J and
DBA/2J of selected genes in the mapped QTLs.
Found at: doi:10.1371/journal.ppat.1000042.s003 (0.05 MB XLS)
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